Click for best price
Pulmonary Drug Delivery Devices Market Size, Share 2024
| Market size in 2023 |
US$ 2674.5 million
|
Forecast Market size by 2030 |
US$ 3724.7 million
|
| Growth Rate |
CAGR of 4.4% |
Number of Pages |
161 Pages |
This research report provides a comprehensive analysis of the Pulmonary Drug Delivery Devices market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Pulmonary Drug Delivery Devices market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Pulmonary Drug Delivery Devices, challenges faced by the industry, and potential opportunities for market players.
The global Pulmonary Drug Delivery Devices market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Pulmonary Drug Delivery Devices market presents opportunities for various stakeholders, including Asthma, COPD. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Pulmonary Drug Delivery Devices market. Additionally, the growing consumer demand present avenues for market expansion.
The global Pulmonary Drug Delivery Devices market was valued at US$ 2674.5 million in 2023 and is projected to reach US$ 3724.7 million by 2030, at a CAGR of 4.4% during the forecast period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Key Features:
The research report on the Pulmonary Drug Delivery Devices market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Pulmonary Drug Delivery Devices market.
Market Overview: The report provides a comprehensive overview of the Pulmonary Drug Delivery Devices market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., Dry Powder Inhaler, Metered Dose Inhaler), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the Pulmonary Drug Delivery Devices market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Pulmonary Drug Delivery Devices market's trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Pulmonary Drug Delivery Devices market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the Pulmonary Drug Delivery Devices market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the Pulmonary Drug Delivery Devices market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Pulmonary Drug Delivery Devices market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Pulmonary Drug Delivery Devices, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Pulmonary Drug Delivery Devices market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
Pulmonary Drug Delivery Devices market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Dry Powder Inhaler
Metered Dose Inhaler
Nebulizer
Market segment by Application
Asthma
COPD
Cystic Fibrosis
Other
Global Pulmonary Drug Delivery Devices Market Segment Percentages, By Region and Country, 2023 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Major players covered
Boehringer Ingelheim GmbH
Novartis AG
GlaxoSmithKline
AstraZeneca
Teva Pharmaceutical Industries
Merck
MannKind
Bristol-Myers Squibb
Mylan N.V
Omron Corp
F. Hoffmann-La Roche
3M Healthcare
Sunovion Pharmaceuticals
Koninklijke Philips N.V
Gerresheimer AG
Bespak
AptarGroup
SHL Group
Nypro Healthcare
Hovione
Chiesi Farmaceutici S.P.A
Outline of Major Chapters:
Chapter 1: Introduces the definition of Pulmonary Drug Delivery Devices, market overview.
Chapter 2: Global Pulmonary Drug Delivery Devices market size in revenue and volume.
Chapter 3: Detailed analysis of Pulmonary Drug Delivery Devices manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Pulmonary Drug Delivery Devices in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Pulmonary Drug Delivery Devices capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Pulmonary Drug Delivery Devices Market, Global Outlook and Forecast 2024-2030 |
| Market size in 2023 |
US$ 2674.5 million
|
| Forecast Market size by 2030 |
US$ 3724.7 million
|
| Growth Rate |
CAGR of 4.4% |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2023 |
| Forecast Year |
2031 |
| Number of Pages |
161 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Pulmonary Drug Delivery Devices Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Pulmonary Drug Delivery Devices Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Pulmonary Drug Delivery Devices Overall Market Size
2.1 Global Pulmonary Drug Delivery Devices Market Size: 2023 VS 2030
2.2 Global Pulmonary Drug Delivery Devices Revenue, Prospects & Forecasts: 2019-2030
2.3 Global Pulmonary Drug Delivery Devices Sales: 2019-2030
3 Company Landscape
3.1 Top Pulmonary Drug Delivery Devices Players in Global Market
3.2 Top Global Pulmonary Drug Delivery Devices Companies Ranked by Revenue
3.3 Global Pulmonary Drug Delivery Devices Revenue by Companies
3.4 Global Pulmonary Drug Delivery Devices Sales by Companies
3.5 Global Pulmonary Drug Delivery Devices Price by Manufacturer (2019-2024)
3.6 Top 3 and Top 5 Pulmonary Drug Delivery Devices Companies in Global Market, by Revenue in 2023
3.7 Global Manufacturers Pulmonary Drug Delivery Devices Product Type
3.8 Tier 1, Tier 2 and Tier 3 Pulmonary Drug Delivery Devices Players in Global Market
3.8.1 List of Global Tier 1 Pulmonary Drug Delivery Devices Companies
3.8.2 List of Global Tier 2 and Tier 3 Pulmonary Drug Delivery Devices Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Pulmonary Drug Delivery Devices Market Size Markets, 2023 & 2030
4.1.2 Dry Powder Inhaler
4.1.3 Metered Dose Inhaler
4.1.4 Nebulizer
4.2 By Type - Global Pulmonary Drug Delivery Devices Revenue & Forecasts
4.2.1 By Type - Global Pulmonary Drug Delivery Devices Revenue, 2019-2024
4.2.2 By Type - Global Pulmonary Drug Delivery Devices Revenue, 2025-2030
4.2.3 By Type - Global Pulmonary Drug Delivery Devices Revenue Market Share, 2019-2030
4.3 By Type - Global Pulmonary Drug Delivery Devices Sales & Forecasts
4.3.1 By Type - Global Pulmonary Drug Delivery Devices Sales, 2019-2024
4.3.2 By Type - Global Pulmonary Drug Delivery Devices Sales, 2025-2030
4.3.3 By Type - Global Pulmonary Drug Delivery Devices Sales Market Share, 2019-2030
4.4 By Type - Global Pulmonary Drug Delivery Devices Price (Manufacturers Selling Prices), 2019-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Pulmonary Drug Delivery Devices Market Size, 2023 & 2030
5.1.2 Asthma
5.1.3 COPD
5.1.4 Cystic Fibrosis
5.1.5 Other
5.2 By Application - Global Pulmonary Drug Delivery Devices Revenue & Forecasts
5.2.1 By Application - Global Pulmonary Drug Delivery Devices Revenue, 2019-2024
5.2.2 By Application - Global Pulmonary Drug Delivery Devices Revenue, 2025-2030
5.2.3 By Application - Global Pulmonary Drug Delivery Devices Revenue Market Share, 2019-2030
5.3 By Application - Global Pulmonary Drug Delivery Devices Sales & Forecasts
5.3.1 By Application - Global Pulmonary Drug Delivery Devices Sales, 2019-2024
5.3.2 By Application - Global Pulmonary Drug Delivery Devices Sales, 2025-2030
5.3.3 By Application - Global Pulmonary Drug Delivery Devices Sales Market Share, 2019-2030
5.4 By Application - Global Pulmonary Drug Delivery Devices Price (Manufacturers Selling Prices), 2019-2030
6 Sights by Region
6.1 By Region - Global Pulmonary Drug Delivery Devices Market Size, 2023 & 2030
6.2 By Region - Global Pulmonary Drug Delivery Devices Revenue & Forecasts
6.2.1 By Region - Global Pulmonary Drug Delivery Devices Revenue, 2019-2024
6.2.2 By Region - Global Pulmonary Drug Delivery Devices Revenue, 2025-2030
6.2.3 By Region - Global Pulmonary Drug Delivery Devices Revenue Market Share, 2019-2030
6.3 By Region - Global Pulmonary Drug Delivery Devices Sales & Forecasts
6.3.1 By Region - Global Pulmonary Drug Delivery Devices Sales, 2019-2024
6.3.2 By Region - Global Pulmonary Drug Delivery Devices Sales, 2025-2030
6.3.3 By Region - Global Pulmonary Drug Delivery Devices Sales Market Share, 2019-2030
6.4 North America
6.4.1 By Country - North America Pulmonary Drug Delivery Devices Revenue, 2019-2030
6.4.2 By Country - North America Pulmonary Drug Delivery Devices Sales, 2019-2030
6.4.3 US Pulmonary Drug Delivery Devices Market Size, 2019-2030
6.4.4 Canada Pulmonary Drug Delivery Devices Market Size, 2019-2030
6.4.5 Mexico Pulmonary Drug Delivery Devices Market Size, 2019-2030
6.5 Europe
6.5.1 By Country - Europe Pulmonary Drug Delivery Devices Revenue, 2019-2030
6.5.2 By Country - Europe Pulmonary Drug Delivery Devices Sales, 2019-2030
6.5.3 Germany Pulmonary Drug Delivery Devices Market Size, 2019-2030
6.5.4 France Pulmonary Drug Delivery Devices Market Size, 2019-2030
6.5.5 U.K. Pulmonary Drug Delivery Devices Market Size, 2019-2030
6.5.6 Italy Pulmonary Drug Delivery Devices Market Size, 2019-2030
6.5.7 Russia Pulmonary Drug Delivery Devices Market Size, 2019-2030
6.5.8 Nordic Countries Pulmonary Drug Delivery Devices Market Size, 2019-2030
6.5.9 Benelux Pulmonary Drug Delivery Devices Market Size, 2019-2030
6.6 Asia
6.6.1 By Region - Asia Pulmonary Drug Delivery Devices Revenue, 2019-2030
6.6.2 By Region - Asia Pulmonary Drug Delivery Devices Sales, 2019-2030
6.6.3 China Pulmonary Drug Delivery Devices Market Size, 2019-2030
6.6.4 Japan Pulmonary Drug Delivery Devices Market Size, 2019-2030
6.6.5 South Korea Pulmonary Drug Delivery Devices Market Size, 2019-2030
6.6.6 Southeast Asia Pulmonary Drug Delivery Devices Market Size, 2019-2030
6.6.7 India Pulmonary Drug Delivery Devices Market Size, 2019-2030
6.7 South America
6.7.1 By Country - South America Pulmonary Drug Delivery Devices Revenue, 2019-2030
6.7.2 By Country - South America Pulmonary Drug Delivery Devices Sales, 2019-2030
6.7.3 Brazil Pulmonary Drug Delivery Devices Market Size, 2019-2030
6.7.4 Argentina Pulmonary Drug Delivery Devices Market Size, 2019-2030
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Pulmonary Drug Delivery Devices Revenue, 2019-2030
6.8.2 By Country - Middle East & Africa Pulmonary Drug Delivery Devices Sales, 2019-2030
6.8.3 Turkey Pulmonary Drug Delivery Devices Market Size, 2019-2030
6.8.4 Israel Pulmonary Drug Delivery Devices Market Size, 2019-2030
6.8.5 Saudi Arabia Pulmonary Drug Delivery Devices Market Size, 2019-2030
6.8.6 UAE Pulmonary Drug Delivery Devices Market Size, 2019-2030
7 Manufacturers & Brands Profiles
7.1 Boehringer Ingelheim GmbH
7.1.1 Boehringer Ingelheim GmbH Company Summary
7.1.2 Boehringer Ingelheim GmbH Business Overview
7.1.3 Boehringer Ingelheim GmbH Pulmonary Drug Delivery Devices Major Product Offerings
7.1.4 Boehringer Ingelheim GmbH Pulmonary Drug Delivery Devices Sales and Revenue in Global (2019-2024)
7.1.5 Boehringer Ingelheim GmbH Key News & Latest Developments
7.2 Novartis AG
7.2.1 Novartis AG Company Summary
7.2.2 Novartis AG Business Overview
7.2.3 Novartis AG Pulmonary Drug Delivery Devices Major Product Offerings
7.2.4 Novartis AG Pulmonary Drug Delivery Devices Sales and Revenue in Global (2019-2024)
7.2.5 Novartis AG Key News & Latest Developments
7.3 GlaxoSmithKline
7.3.1 GlaxoSmithKline Company Summary
7.3.2 GlaxoSmithKline Business Overview
7.3.3 GlaxoSmithKline Pulmonary Drug Delivery Devices Major Product Offerings
7.3.4 GlaxoSmithKline Pulmonary Drug Delivery Devices Sales and Revenue in Global (2019-2024)
7.3.5 GlaxoSmithKline Key News & Latest Developments
7.4 AstraZeneca
7.4.1 AstraZeneca Company Summary
7.4.2 AstraZeneca Business Overview
7.4.3 AstraZeneca Pulmonary Drug Delivery Devices Major Product Offerings
7.4.4 AstraZeneca Pulmonary Drug Delivery Devices Sales and Revenue in Global (2019-2024)
7.4.5 AstraZeneca Key News & Latest Developments
7.5 Teva Pharmaceutical Industries
7.5.1 Teva Pharmaceutical Industries Company Summary
7.5.2 Teva Pharmaceutical Industries Business Overview
7.5.3 Teva Pharmaceutical Industries Pulmonary Drug Delivery Devices Major Product Offerings
7.5.4 Teva Pharmaceutical Industries Pulmonary Drug Delivery Devices Sales and Revenue in Global (2019-2024)
7.5.5 Teva Pharmaceutical Industries Key News & Latest Developments
7.6 Merck
7.6.1 Merck Company Summary
7.6.2 Merck Business Overview
7.6.3 Merck Pulmonary Drug Delivery Devices Major Product Offerings
7.6.4 Merck Pulmonary Drug Delivery Devices Sales and Revenue in Global (2019-2024)
7.6.5 Merck Key News & Latest Developments
7.7 MannKind
7.7.1 MannKind Company Summary
7.7.2 MannKind Business Overview
7.7.3 MannKind Pulmonary Drug Delivery Devices Major Product Offerings
7.7.4 MannKind Pulmonary Drug Delivery Devices Sales and Revenue in Global (2019-2024)
7.7.5 MannKind Key News & Latest Developments
7.8 Bristol-Myers Squibb
7.8.1 Bristol-Myers Squibb Company Summary
7.8.2 Bristol-Myers Squibb Business Overview
7.8.3 Bristol-Myers Squibb Pulmonary Drug Delivery Devices Major Product Offerings
7.8.4 Bristol-Myers Squibb Pulmonary Drug Delivery Devices Sales and Revenue in Global (2019-2024)
7.8.5 Bristol-Myers Squibb Key News & Latest Developments
7.9 Mylan N.V
7.9.1 Mylan N.V Company Summary
7.9.2 Mylan N.V Business Overview
7.9.3 Mylan N.V Pulmonary Drug Delivery Devices Major Product Offerings
7.9.4 Mylan N.V Pulmonary Drug Delivery Devices Sales and Revenue in Global (2019-2024)
7.9.5 Mylan N.V Key News & Latest Developments
7.10 Omron Corp
7.10.1 Omron Corp Company Summary
7.10.2 Omron Corp Business Overview
7.10.3 Omron Corp Pulmonary Drug Delivery Devices Major Product Offerings
7.10.4 Omron Corp Pulmonary Drug Delivery Devices Sales and Revenue in Global (2019-2024)
7.10.5 Omron Corp Key News & Latest Developments
7.11 F. Hoffmann-La Roche
7.11.1 F. Hoffmann-La Roche Company Summary
7.11.2 F. Hoffmann-La Roche Business Overview
7.11.3 F. Hoffmann-La Roche Pulmonary Drug Delivery Devices Major Product Offerings
7.11.4 F. Hoffmann-La Roche Pulmonary Drug Delivery Devices Sales and Revenue in Global (2019-2024)
7.11.5 F. Hoffmann-La Roche Key News & Latest Developments
7.12 3M Healthcare
7.12.1 3M Healthcare Company Summary
7.12.2 3M Healthcare Business Overview
7.12.3 3M Healthcare Pulmonary Drug Delivery Devices Major Product Offerings
7.12.4 3M Healthcare Pulmonary Drug Delivery Devices Sales and Revenue in Global (2019-2024)
7.12.5 3M Healthcare Key News & Latest Developments
7.13 Sunovion Pharmaceuticals
7.13.1 Sunovion Pharmaceuticals Company Summary
7.13.2 Sunovion Pharmaceuticals Business Overview
7.13.3 Sunovion Pharmaceuticals Pulmonary Drug Delivery Devices Major Product Offerings
7.13.4 Sunovion Pharmaceuticals Pulmonary Drug Delivery Devices Sales and Revenue in Global (2019-2024)
7.13.5 Sunovion Pharmaceuticals Key News & Latest Developments
7.14 Koninklijke Philips N.V
7.14.1 Koninklijke Philips N.V Company Summary
7.14.2 Koninklijke Philips N.V Business Overview
7.14.3 Koninklijke Philips N.V Pulmonary Drug Delivery Devices Major Product Offerings
7.14.4 Koninklijke Philips N.V Pulmonary Drug Delivery Devices Sales and Revenue in Global (2019-2024)
7.14.5 Koninklijke Philips N.V Key News & Latest Developments
7.15 Gerresheimer AG
7.15.1 Gerresheimer AG Company Summary
7.15.2 Gerresheimer AG Business Overview
7.15.3 Gerresheimer AG Pulmonary Drug Delivery Devices Major Product Offerings
7.15.4 Gerresheimer AG Pulmonary Drug Delivery Devices Sales and Revenue in Global (2019-2024)
7.15.5 Gerresheimer AG Key News & Latest Developments
7.16 Bespak
7.16.1 Bespak Company Summary
7.16.2 Bespak Business Overview
7.16.3 Bespak Pulmonary Drug Delivery Devices Major Product Offerings
7.16.4 Bespak Pulmonary Drug Delivery Devices Sales and Revenue in Global (2019-2024)
7.16.5 Bespak Key News & Latest Developments
7.17 AptarGroup
7.17.1 AptarGroup Company Summary
7.17.2 AptarGroup Business Overview
7.17.3 AptarGroup Pulmonary Drug Delivery Devices Major Product Offerings
7.17.4 AptarGroup Pulmonary Drug Delivery Devices Sales and Revenue in Global (2019-2024)
7.17.5 AptarGroup Key News & Latest Developments
7.18 SHL Group
7.18.1 SHL Group Company Summary
7.18.2 SHL Group Business Overview
7.18.3 SHL Group Pulmonary Drug Delivery Devices Major Product Offerings
7.18.4 SHL Group Pulmonary Drug Delivery Devices Sales and Revenue in Global (2019-2024)
7.18.5 SHL Group Key News & Latest Developments
7.19 Nypro Healthcare
7.19.1 Nypro Healthcare Company Summary
7.19.2 Nypro Healthcare Business Overview
7.19.3 Nypro Healthcare Pulmonary Drug Delivery Devices Major Product Offerings
7.19.4 Nypro Healthcare Pulmonary Drug Delivery Devices Sales and Revenue in Global (2019-2024)
7.19.5 Nypro Healthcare Key News & Latest Developments
7.20 Hovione
7.20.1 Hovione Company Summary
7.20.2 Hovione Business Overview
7.20.3 Hovione Pulmonary Drug Delivery Devices Major Product Offerings
7.20.4 Hovione Pulmonary Drug Delivery Devices Sales and Revenue in Global (2019-2024)
7.20.5 Hovione Key News & Latest Developments
7.21 Chiesi Farmaceutici S.P.A
7.21.1 Chiesi Farmaceutici S.P.A Company Summary
7.21.2 Chiesi Farmaceutici S.P.A Business Overview
7.21.3 Chiesi Farmaceutici S.P.A Pulmonary Drug Delivery Devices Major Product Offerings
7.21.4 Chiesi Farmaceutici S.P.A Pulmonary Drug Delivery Devices Sales and Revenue in Global (2019-2024)
7.21.5 Chiesi Farmaceutici S.P.A Key News & Latest Developments
8 Global Pulmonary Drug Delivery Devices Production Capacity, Analysis
8.1 Global Pulmonary Drug Delivery Devices Production Capacity, 2019-2030
8.2 Pulmonary Drug Delivery Devices Production Capacity of Key Manufacturers in Global Market
8.3 Global Pulmonary Drug Delivery Devices Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Pulmonary Drug Delivery Devices Supply Chain Analysis
10.1 Pulmonary Drug Delivery Devices Industry Value Chain
10.2 Pulmonary Drug Delivery Devices Upstream Market
10.3 Pulmonary Drug Delivery Devices Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Pulmonary Drug Delivery Devices Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Pulmonary Drug Delivery Devices in Global Market
Table 2. Top Pulmonary Drug Delivery Devices Players in Global Market, Ranking by Revenue (2023)
Table 3. Global Pulmonary Drug Delivery Devices Revenue by Companies, (US$, Mn), 2019-2024
Table 4. Global Pulmonary Drug Delivery Devices Revenue Share by Companies, 2019-2024
Table 5. Global Pulmonary Drug Delivery Devices Sales by Companies, (K Units), 2019-2024
Table 6. Global Pulmonary Drug Delivery Devices Sales Share by Companies, 2019-2024
Table 7. Key Manufacturers Pulmonary Drug Delivery Devices Price (2019-2024) & (USD/Unit)
Table 8. Global Manufacturers Pulmonary Drug Delivery Devices Product Type
Table 9. List of Global Tier 1 Pulmonary Drug Delivery Devices Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Pulmonary Drug Delivery Devices Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 11. By Type ? Global Pulmonary Drug Delivery Devices Revenue, (US$, Mn), 2023 & 2030
Table 12. By Type - Global Pulmonary Drug Delivery Devices Revenue (US$, Mn), 2019-2024
Table 13. By Type - Global Pulmonary Drug Delivery Devices Revenue (US$, Mn), 2025-2030
Table 14. By Type - Global Pulmonary Drug Delivery Devices Sales (K Units), 2019-2024
Table 15. By Type - Global Pulmonary Drug Delivery Devices Sales (K Units), 2025-2030
Table 16. By Application ? Global Pulmonary Drug Delivery Devices Revenue, (US$, Mn), 2023 & 2030
Table 17. By Application - Global Pulmonary Drug Delivery Devices Revenue (US$, Mn), 2019-2024
Table 18. By Application - Global Pulmonary Drug Delivery Devices Revenue (US$, Mn), 2025-2030
Table 19. By Application - Global Pulmonary Drug Delivery Devices Sales (K Units), 2019-2024
Table 20. By Application - Global Pulmonary Drug Delivery Devices Sales (K Units), 2025-2030
Table 21. By Region ? Global Pulmonary Drug Delivery Devices Revenue, (US$, Mn), 2023 VS 2030
Table 22. By Region - Global Pulmonary Drug Delivery Devices Revenue (US$, Mn), 2019-2024
Table 23. By Region - Global Pulmonary Drug Delivery Devices Revenue (US$, Mn), 2025-2030
Table 24. By Region - Global Pulmonary Drug Delivery Devices Sales (K Units), 2019-2024
Table 25. By Region - Global Pulmonary Drug Delivery Devices Sales (K Units), 2025-2030
Table 26. By Country - North America Pulmonary Drug Delivery Devices Revenue, (US$, Mn), 2019-2024
Table 27. By Country - North America Pulmonary Drug Delivery Devices Revenue, (US$, Mn), 2025-2030
Table 28. By Country - North America Pulmonary Drug Delivery Devices Sales, (K Units), 2019-2024
Table 29. By Country - North America Pulmonary Drug Delivery Devices Sales, (K Units), 2025-2030
Table 30. By Country - Europe Pulmonary Drug Delivery Devices Revenue, (US$, Mn), 2019-2024
Table 31. By Country - Europe Pulmonary Drug Delivery Devices Revenue, (US$, Mn), 2025-2030
Table 32. By Country - Europe Pulmonary Drug Delivery Devices Sales, (K Units), 2019-2024
Table 33. By Country - Europe Pulmonary Drug Delivery Devices Sales, (K Units), 2025-2030
Table 34. By Region - Asia Pulmonary Drug Delivery Devices Revenue, (US$, Mn), 2019-2024
Table 35. By Region - Asia Pulmonary Drug Delivery Devices Revenue, (US$, Mn), 2025-2030
Table 36. By Region - Asia Pulmonary Drug Delivery Devices Sales, (K Units), 2019-2024
Table 37. By Region - Asia Pulmonary Drug Delivery Devices Sales, (K Units), 2025-2030
Table 38. By Country - South America Pulmonary Drug Delivery Devices Revenue, (US$, Mn), 2019-2024
Table 39. By Country - South America Pulmonary Drug Delivery Devices Revenue, (US$, Mn), 2025-2030
Table 40. By Country - South America Pulmonary Drug Delivery Devices Sales, (K Units), 2019-2024
Table 41. By Country - South America Pulmonary Drug Delivery Devices Sales, (K Units), 2025-2030
Table 42. By Country - Middle East & Africa Pulmonary Drug Delivery Devices Revenue, (US$, Mn), 2019-2024
Table 43. By Country - Middle East & Africa Pulmonary Drug Delivery Devices Revenue, (US$, Mn), 2025-2030
Table 44. By Country - Middle East & Africa Pulmonary Drug Delivery Devices Sales, (K Units), 2019-2024
Table 45. By Country - Middle East & Africa Pulmonary Drug Delivery Devices Sales, (K Units), 2025-2030
Table 46. Boehringer Ingelheim GmbH Company Summary
Table 47. Boehringer Ingelheim GmbH Pulmonary Drug Delivery Devices Product Offerings
Table 48. Boehringer Ingelheim GmbH Pulmonary Drug Delivery Devices Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2019-2024)
Table 49. Boehringer Ingelheim GmbH Key News & Latest Developments
Table 50. Novartis AG Company Summary
Table 51. Novartis AG Pulmonary Drug Delivery Devices Product Offerings
Table 52. Novartis AG Pulmonary Drug Delivery Devices Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2019-2024)
Table 53. Novartis AG Key News & Latest Developments
Table 54. GlaxoSmithKline Company Summary
Table 55. GlaxoSmithKline Pulmonary Drug Delivery Devices Product Offerings
Table 56. GlaxoSmithKline Pulmonary Drug Delivery Devices Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2019-2024)
Table 57. GlaxoSmithKline Key News & Latest Developments
Table 58. AstraZeneca Company Summary
Table 59. AstraZeneca Pulmonary Drug Delivery Devices Product Offerings
Table 60. AstraZeneca Pulmonary Drug Delivery Devices Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2019-2024)
Table 61. AstraZeneca Key News & Latest Developments
Table 62. Teva Pharmaceutical Industries Company Summary
Table 63. Teva Pharmaceutical Industries Pulmonary Drug Delivery Devices Product Offerings
Table 64. Teva Pharmaceutical Industries Pulmonary Drug Delivery Devices Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2019-2024)
Table 65. Teva Pharmaceutical Industries Key News & Latest Developments
Table 66. Merck Company Summary
Table 67. Merck Pulmonary Drug Delivery Devices Product Offerings
Table 68. Merck Pulmonary Drug Delivery Devices Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2019-2024)
Table 69. Merck Key News & Latest Developments
Table 70. MannKind Company Summary
Table 71. MannKind Pulmonary Drug Delivery Devices Product Offerings
Table 72. MannKind Pulmonary Drug Delivery Devices Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2019-2024)
Table 73. MannKind Key News & Latest Developments
Table 74. Bristol-Myers Squibb Company Summary
Table 75. Bristol-Myers Squibb Pulmonary Drug Delivery Devices Product Offerings
Table 76. Bristol-Myers Squibb Pulmonary Drug Delivery Devices Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2019-2024)
Table 77. Bristol-Myers Squibb Key News & Latest Developments
Table 78. Mylan N.V Company Summary
Table 79. Mylan N.V Pulmonary Drug Delivery Devices Product Offerings
Table 80. Mylan N.V Pulmonary Drug Delivery Devices Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2019-2024)
Table 81. Mylan N.V Key News & Latest Developments
Table 82. Omron Corp Company Summary
Table 83. Omron Corp Pulmonary Drug Delivery Devices Product Offerings
Table 84. Omron Corp Pulmonary Drug Delivery Devices Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2019-2024)
Table 85. Omron Corp Key News & Latest Developments
Table 86. F. Hoffmann-La Roche Company Summary
Table 87. F. Hoffmann-La Roche Pulmonary Drug Delivery Devices Product Offerings
Table 88. F. Hoffmann-La Roche Pulmonary Drug Delivery Devices Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2019-2024)
Table 89. F. Hoffmann-La Roche Key News & Latest Developments
Table 90. 3M Healthcare Company Summary
Table 91. 3M Healthcare Pulmonary Drug Delivery Devices Product Offerings
Table 92. 3M Healthcare Pulmonary Drug Delivery Devices Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2019-2024)
Table 93. 3M Healthcare Key News & Latest Developments
Table 94. Sunovion Pharmaceuticals Company Summary
Table 95. Sunovion Pharmaceuticals Pulmonary Drug Delivery Devices Product Offerings
Table 96. Sunovion Pharmaceuticals Pulmonary Drug Delivery Devices Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2019-2024)
Table 97. Sunovion Pharmaceuticals Key News & Latest Developments
Table 98. Koninklijke Philips N.V Company Summary
Table 99. Koninklijke Philips N.V Pulmonary Drug Delivery Devices Product Offerings
Table 100. Koninklijke Philips N.V Pulmonary Drug Delivery Devices Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2019-2024)
Table 101. Koninklijke Philips N.V Key News & Latest Developments
Table 102. Gerresheimer AG Company Summary
Table 103. Gerresheimer AG Pulmonary Drug Delivery Devices Product Offerings
Table 104. Gerresheimer AG Pulmonary Drug Delivery Devices Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2019-2024)
Table 105. Gerresheimer AG Key News & Latest Developments
Table 106. Bespak Company Summary
Table 107. Bespak Pulmonary Drug Delivery Devices Product Offerings
Table 108. Bespak Pulmonary Drug Delivery Devices Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2019-2024)
Table 109. Bespak Key News & Latest Developments
Table 110. AptarGroup Company Summary
Table 111. AptarGroup Pulmonary Drug Delivery Devices Product Offerings
Table 112. AptarGroup Pulmonary Drug Delivery Devices Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2019-2024)
Table 113. AptarGroup Key News & Latest Developments
Table 114. SHL Group Company Summary
Table 115. SHL Group Pulmonary Drug Delivery Devices Product Offerings
Table 116. SHL Group Pulmonary Drug Delivery Devices Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2019-2024)
Table 117. SHL Group Key News & Latest Developments
Table 118. Nypro Healthcare Company Summary
Table 119. Nypro Healthcare Pulmonary Drug Delivery Devices Product Offerings
Table 120. Nypro Healthcare Pulmonary Drug Delivery Devices Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2019-2024)
Table 121. Nypro Healthcare Key News & Latest Developments
Table 122. Hovione Company Summary
Table 123. Hovione Pulmonary Drug Delivery Devices Product Offerings
Table 124. Hovione Pulmonary Drug Delivery Devices Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2019-2024)
Table 125. Hovione Key News & Latest Developments
Table 126. Chiesi Farmaceutici S.P.A Company Summary
Table 127. Chiesi Farmaceutici S.P.A Pulmonary Drug Delivery Devices Product Offerings
Table 128. Chiesi Farmaceutici S.P.A Pulmonary Drug Delivery Devices Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2019-2024)
Table 129. Chiesi Farmaceutici S.P.A Key News & Latest Developments
Table 130. Pulmonary Drug Delivery Devices Production Capacity (K Units) of Key Manufacturers in Global Market, 2022-2024 (K Units)
Table 131. Global Pulmonary Drug Delivery Devices Capacity Market Share of Key Manufacturers, 2022-2024
Table 132. Global Pulmonary Drug Delivery Devices Production by Region, 2019-2024 (K Units)
Table 133. Global Pulmonary Drug Delivery Devices Production by Region, 2025-2030 (K Units)
Table 134. Pulmonary Drug Delivery Devices Market Opportunities & Trends in Global Market
Table 135. Pulmonary Drug Delivery Devices Market Drivers in Global Market
Table 136. Pulmonary Drug Delivery Devices Market Restraints in Global Market
Table 137. Pulmonary Drug Delivery Devices Raw Materials
Table 138. Pulmonary Drug Delivery Devices Raw Materials Suppliers in Global Market
Table 139. Typical Pulmonary Drug Delivery Devices Downstream
Table 140. Pulmonary Drug Delivery Devices Downstream Clients in Global Market
Table 141. Pulmonary Drug Delivery Devices Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Pulmonary Drug Delivery Devices Segment by Type in 2023
Figure 2. Pulmonary Drug Delivery Devices Segment by Application in 2023
Figure 3. Global Pulmonary Drug Delivery Devices Market Overview: 2023
Figure 4. Key Caveats
Figure 5. Global Pulmonary Drug Delivery Devices Market Size: 2023 VS 2030 (US$, Mn)
Figure 6. Global Pulmonary Drug Delivery Devices Revenue, 2019-2030 (US$, Mn)
Figure 7. Pulmonary Drug Delivery Devices Sales in Global Market: 2019-2030 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Pulmonary Drug Delivery Devices Revenue in 2023
Figure 9. By Type - Global Pulmonary Drug Delivery Devices Revenue, (US$, Mn), 2023 & 2030
Figure 10. By Type - Global Pulmonary Drug Delivery Devices Revenue Market Share, 2019-2030
Figure 11. By Type - Global Pulmonary Drug Delivery Devices Sales Market Share, 2019-2030
Figure 12. By Type - Global Pulmonary Drug Delivery Devices Price (USD/Unit), 2019-2030
Figure 13. By Application - Global Pulmonary Drug Delivery Devices Revenue, (US$, Mn), 2023 & 2030
Figure 14. By Application - Global Pulmonary Drug Delivery Devices Revenue Market Share, 2019-2030
Figure 15. By Application - Global Pulmonary Drug Delivery Devices Sales Market Share, 2019-2030
Figure 16. By Application - Global Pulmonary Drug Delivery Devices Price (USD/Unit), 2019-2030
Figure 17. By Region - Global Pulmonary Drug Delivery Devices Revenue, (US$, Mn), 2023 & 2030
Figure 18. By Region - Global Pulmonary Drug Delivery Devices Revenue Market Share, 2019 VS 2023 VS 2030
Figure 19. By Region - Global Pulmonary Drug Delivery Devices Revenue Market Share, 2019-2030
Figure 20. By Region - Global Pulmonary Drug Delivery Devices Sales Market Share, 2019-2030
Figure 21. By Country - North America Pulmonary Drug Delivery Devices Revenue Market Share, 2019-2030
Figure 22. By Country - North America Pulmonary Drug Delivery Devices Sales Market Share, 2019-2030
Figure 23. US Pulmonary Drug Delivery Devices Revenue, (US$, Mn), 2019-2030
Figure 24. Canada Pulmonary Drug Delivery Devices Revenue, (US$, Mn), 2019-2030
Figure 25. Mexico Pulmonary Drug Delivery Devices Revenue, (US$, Mn), 2019-2030
Figure 26. By Country - Europe Pulmonary Drug Delivery Devices Revenue Market Share, 2019-2030
Figure 27. By Country - Europe Pulmonary Drug Delivery Devices Sales Market Share, 2019-2030
Figure 28. Germany Pulmonary Drug Delivery Devices Revenue, (US$, Mn), 2019-2030
Figure 29. France Pulmonary Drug Delivery Devices Revenue, (US$, Mn), 2019-2030
Figure 30. U.K. Pulmonary Drug Delivery Devices Revenue, (US$, Mn), 2019-2030
Figure 31. Italy Pulmonary Drug Delivery Devices Revenue, (US$, Mn), 2019-2030
Figure 32. Russia Pulmonary Drug Delivery Devices Revenue, (US$, Mn), 2019-2030
Figure 33. Nordic Countries Pulmonary Drug Delivery Devices Revenue, (US$, Mn), 2019-2030
Figure 34. Benelux Pulmonary Drug Delivery Devices Revenue, (US$, Mn), 2019-2030
Figure 35. By Region - Asia Pulmonary Drug Delivery Devices Revenue Market Share, 2019-2030
Figure 36. By Region - Asia Pulmonary Drug Delivery Devices Sales Market Share, 2019-2030
Figure 37. China Pulmonary Drug Delivery Devices Revenue, (US$, Mn), 2019-2030
Figure 38. Japan Pulmonary Drug Delivery Devices Revenue, (US$, Mn), 2019-2030
Figure 39. South Korea Pulmonary Drug Delivery Devices Revenue, (US$, Mn), 2019-2030
Figure 40. Southeast Asia Pulmonary Drug Delivery Devices Revenue, (US$, Mn), 2019-2030
Figure 41. India Pulmonary Drug Delivery Devices Revenue, (US$, Mn), 2019-2030
Figure 42. By Country - South America Pulmonary Drug Delivery Devices Revenue Market Share, 2019-2030
Figure 43. By Country - South America Pulmonary Drug Delivery Devices Sales Market Share, 2019-2030
Figure 44. Brazil Pulmonary Drug Delivery Devices Revenue, (US$, Mn), 2019-2030
Figure 45. Argentina Pulmonary Drug Delivery Devices Revenue, (US$, Mn), 2019-2030
Figure 46. By Country - Middle East & Africa Pulmonary Drug Delivery Devices Revenue Market Share, 2019-2030
Figure 47. By Country - Middle East & Africa Pulmonary Drug Delivery Devices Sales Market Share, 2019-2030
Figure 48. Turkey Pulmonary Drug Delivery Devices Revenue, (US$, Mn), 2019-2030
Figure 49. Israel Pulmonary Drug Delivery Devices Revenue, (US$, Mn), 2019-2030
Figure 50. Saudi Arabia Pulmonary Drug Delivery Devices Revenue, (US$, Mn), 2019-2030
Figure 51. UAE Pulmonary Drug Delivery Devices Revenue, (US$, Mn), 2019-2030
Figure 52. Global Pulmonary Drug Delivery Devices Production Capacity (K Units), 2019-2030
Figure 53. The Percentage of Production Pulmonary Drug Delivery Devices by Region, 2023 VS 2030
Figure 54. Pulmonary Drug Delivery Devices Industry Value Chain
Figure 55. Marketing Channels
